STOCK TITAN

Form 144: SentinelOne insider to sell 23,520 shares valued $433,474 via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SentinelOne (S) Form 144 shows a proposed sale of 23,520 common shares, valued at $433,473.60, to be sold through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 09/09/2025. The shares were acquired as restricted stock units on 09/05/2025 and the payment/settlement date is listed as 09/05/2025.

The filing also discloses prior sales by the same person or account under 10b5-1 plans: 15,163 shares sold on 08/07/2025 for $252,926.42 and 15,807 shares sold on 08/06/2025 for $273,619.17. The filer represents they are not aware of undisclosed material adverse information and references potential reliance on a Rule 10b5-1 plan.

Positive

  • Clear disclosure of broker, exchange, share counts, acquisition type (RSUs), and transaction dates
  • Prior 10b5-1 sales disclosed, indicating preplanned, rule-compliant liquidity rather than opportunistic timing
  • Filer represents no undisclosed material adverse information in the notice

Negative

  • No specific identity details (filer CIK/CCC and some contact fields are not populated in the provided excerpt)
  • Rule 10b5-1 plan adoption date is not shown in the visible Remarks section, leaving plan timing unclear from this extract

Insights

TL;DR: Routine insider sale of newly vested RSUs and recent 10b5-1 plan sales; amounts are modest relative to large-cap equity pools.

The proposed sale of 23,520 RSU-derived shares for $433,474 appears to be a standard disposition following vesting. The filing notes acquisition by restricted stock units on 09/05/2025 with immediate settlement, indicating a post-vesting sale rather than a disposal of long-held stock. Prior 10b5-1 sales in August totaling 30,970 shares for roughly $526,545 show ongoing, preplanned liquidity activity. For investors, these transactions document insider liquidity but do not, by themselves, indicate company operating changes.

TL;DR: Disclosure follows Rule 144 and references 10b5-1; procedural compliance appears intact from the filing details provided.

The form identifies the broker, exchange, share counts, acquisition type (RSUs), and dates, and includes the filer representation regarding material nonpublic information and Rule 10b5-1 plan adoption date field (left blank in the displayed content). The filing does not show any atypical transfer mechanism or related-party complication. Governance-wise, repeated 10b5-1 sales suggest the insider is using scheduled plans to avoid timing concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SentinelOne's (S) Form 144 say about the proposed sale?

The filer proposes to sell 23,520 common shares on 09/09/2025 via Morgan Stanley Smith Barney on the NYSE, valued at $433,473.60.

How were the 23,520 shares acquired according to the filing?

The shares were acquired as Restricted Stock Units on 09/05/2025 and the filing lists the date of payment/settlement as 09/05/2025.

Has the filer sold other SentinelOne (S) shares recently?

Yes. The filing lists two 10b5-1 sales: 15,163 shares on 08/07/2025 for $252,926.42 and 15,807 shares on 08/06/2025 for $273,619.17.

Which broker and exchange are used for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services and the exchange is the NYSE.

Does the Form 144 indicate reliance on a Rule 10b5-1 trading plan?

The filing references Rule 10b5-1 and displays prior 10b5-1 sales, but the visible extract does not show a specific plan adoption date.
Sentinelone Inc

NYSE:S

S Rankings

S Latest News

S Latest SEC Filings

S Stock Data

4.78B
329.90M
0.78%
82.9%
4.5%
Software - Infrastructure
Services-prepackaged Software
Link
United States
MOUNTAIN VIEW